KITLG and endothelial dysfunction: Exhibiting the relationship between SCF progression and endothelial dysfunction is important.4 Therefore, nebivolol, an agent that improves endothelial dysfunction by inducing L-arginine/nitric oxide pathway-dependent vasodilatation, was used in the present study.